Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

It is widely held that cells with metastatic properties such as invasiveness and expression of matrix metalloproteinases arise through the stepwise accumulation of genetic lesions arising from genetic instability and "clonal evolution." By contrast, we show here that in melanomas invasiveness can be regulated epigenetically by the microphthalmia-associated transcription factor, Mitf, via regulation of the DIAPH1 gene encoding the diaphanous-related formin Dia1 that promotes actin polymerization and coordinates the actin cytoskeleton and microtubule networks at the cell periphery. Low Mitf levels lead to down-regulation of Dia1, reorganization of the actin cytoskeleton, and increased ROCK-dependent invasiveness, whereas increased Mitf expression leads to decreased invasiveness. Significantly the regulation of Dia1 by Mitf also controls p27(Kip1)-degradation such that reduced Mitf levels lead to a p27(Kip1)-dependent G1 arrest. Thus Mitf, via regulation of Dia1, can both inhibit invasiveness and promote proliferation. The results imply variations in the repertoire of environmental cues that determine Mitf activity will dictate the differentiation, proliferative, and invasive/migratory potential of melanoma cells through a dynamic epigenetic mechanism.

[1]  J. Vasiliev.  Cytoskeletal mechanisms responsible for invasive migration of neoplastic cells. , 2004, The International journal of developmental biology.

[2]  E. Nishida,et al.  Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization , 1998, Nature.

[3]  Stephen L. Lessnick,et al.  β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor , 2002, The Journal of Cell Biology.

[4]  L. Chin,et al.  Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.

[5]  P. Caroni,et al.  Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase , 1998, Nature.

[6]  M. Khaled,et al.  The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. , 2005, Genes & development.

[7]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[8]  E. Medrano,et al.  Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. , 2005, Pigment cell research.

[9]  M. Hendrix,et al.  Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells , 2003, Annals of the New York Academy of Sciences.

[10]  L. Chin,et al.  Malignant melanoma: modern black plague and genetic black box. , 1998, Genes & development.

[11]  D. Fisher,et al.  Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche , 2005, Science.

[12]  L. Chin,et al.  Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. , 2005, Cancer research.

[13]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[14]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[15]  N. Copeland,et al.  Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.

[16]  Keith W. Vance,et al.  Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. , 2005, Cancer research.

[17]  M. Piris,et al.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. , 2004, The American journal of pathology.

[18]  Hong Sun,et al.  p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 , 1999, Current Biology.

[19]  T. Golub,et al.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.

[20]  L. Larue,et al.  Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression , 2005, Nature.

[21]  Alan Hall,et al.  Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.

[22]  H. Pehamberger,et al.  The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. , 2002, Cancer research.

[23]  D. Schadendorf,et al.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.

[24]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[25]  D. Ingber,et al.  Role of RhoA, mDia, and ROCK in Cell Shape-dependent Control of the Skp2-p27kip1 Pathway and the G1/S Transition* , 2004, Journal of Biological Chemistry.

[26]  P. Friedl.  Prespecification and plasticity: shifting mechanisms of cell migration. , 2004, Current opinion in cell biology.

[27]  C. Goding,et al.  The Gene Encoding the T-box Factor Tbx2 Is a Target for the Microphthalmia-associated Transcription Factor in Melanocytes* , 2000, The Journal of Biological Chemistry.

[28]  J. Nesland,et al.  Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. , 1998, The American journal of pathology.

[29]  H. Murakami,et al.  Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. , 2005, Pigment cell research.

[30]  D. Fisher,et al.  Sumoylation of MITF and Its Related Family Members TFE3 and TFEB* , 2005, Journal of Biological Chemistry.

[31]  S. Corre,et al.  Upstream stimulating factors: highly versatile stress-responsive transcription factors. , 2005, Pigment cell research.

[32]  C. Marshall,et al.  Cdc42–MRCK and Rho–ROCK signalling cooperate in myosin phosphorylation and cell invasion , 2005, Nature Cell Biology.

[33]  J. Becker,et al.  Role of matrix metalloproteinases in melanoma cell invasion. , 2005, Biochimie.

[34]  T. Golub,et al.  Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. , 2004, Cancer cell.

[35]  Keith W. Vance,et al.  Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor , 2004, Cancer Research.

[36]  C. Sheehan,et al.  Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship * , 2004, Journal of cutaneous pathology.

[37]  K. Kraemer.  NRAS hypermutability in familial melanoma with CDKN2A mutations--cause and effect? , 2003, Journal of the National Cancer Institute.

[38]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[39]  R. Marais,et al.  Elevated expression of MITF counteracts B-RAF–stimulated melanocyte and melanoma cell proliferation , 2005, The Journal of cell biology.

[40]  Keith W. Vance,et al.  The transcription network regulating melanocyte development and melanoma. , 2004, Pigment cell research.

[41]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[42]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.

[43]  D. Maric,et al.  MITF and cell proliferation: the role of alternative splice forms. , 2005, Pigment cell research.

[44]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[45]  G. Scott.  Rac and rho: the story behind melanocyte dendrite formation. , 2002, Pigment cell research.

[46]  R. Delston,et al.  MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A , 2005, The Journal of cell biology.

[47]  T. Hirobe.  Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. , 2005, Pigment cell research.

[48]  E. Medrano,et al.  High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas. , 1999, The Journal of investigative dermatology.

[49]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[50]  Jean-Philippe Brunet,et al.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.

[51]  D. Bennett,et al.  Protein tyrosine kinases in malignant melanoma. , 2000, Melanoma research.

[52]  R. Halaban,et al.  Melanomas, from the cell cycle point of view (Review). , 1998, International journal of molecular medicine.

[53]  R. Birge,et al.  ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts , 2002, The Journal of cell biology.

[54]  J. Marshall,et al.  Cell Proliferation Profile of Five Human Uveal Melanoma Cell Lines of Different Metastatic Potential , 2002, Pathobiology.

[55]  E. Sahai,et al.  ROCK and Dia have opposing effects on adherens junctions downstream of Rho , 2002, Nature Cell Biology.

[56]  A. Alberts.  Diaphanous-related Formin homology proteins , 2002, Current Biology.

[57]  W. Pavan,et al.  Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. , 1997, Development.

[58]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[59]  M. Herlyn,et al.  Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.